Equipment and Services Health Care Equipment and Supplies

  • The report, which caused St Jude shares to decline after its release on Thursday, alleged there were significant security bugs in the company's Merlinzhome device for monitoring implanted heart devices. St. Jude initially responded on Thursday with a terse statement from its chief technology officer, Phil Ebeling, who said "the allegations are absolutely...

  • Aug 26- Medical device manufacturer St. Jude Medical Inc said on Friday that a report by short-selling firm Muddy Waters and a cyber-security researcher alleging its heart devices were riddled with bugs was "false and misleading." The report, which caused St Jude shares to decline after its release on Thursday, alleged there were significant security bugs in the...

  • St. Jude refutes Muddy Waters' claims

    Carson Block, Muddy Waters Research founder, and Justine Bone, MedSec Holdings CEO, discuss St. Jude and their response to Muddy Water's claims saying the company's cardiac devices are vulnerable to cyber attacks.

  • St. Jude halted for news

    CNBC's Susan Li reports on why St. Jude Medical is being halted from trade.

  • Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall, claiming its implanted heart devices were vulnerable to cyber attacks. Muddy Waters head Carson Block said the firm's position was motivated by research from a cyber security firm, MedSec Holdings Inc, which has a financial...

  • Aug 25- The stock of pacemaker manufacturer St Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall because of cyber security vulnerabilities in the company's cardiac devices. Muddy Waters head Carson Block said his short position in St Jude was motivated by research from a cyber...

  • Aug 25- Shares of medical device maker St Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall because of cyber security vulnerabilities in cardiac devices made by St Jude. Muddy Waters head Carson Block said his short position in St Jude was motivated by research from a cyber...

  • Aug 25- Shares of medical device maker St Jude Medical Inc fell sharply on Thursday after short-selling firm Muddy Waters said it had placed a bet that the shares would fall because of cyber security vulnerabilities in a cardiac device. Shares of St Jude, which agreed in April to be purchased by Abbott Laboratories, were last down nearly 4 percent on heavy volume...

  • Aug 18- The U.S. Food and Drug Administration has widened the use of Edwards Lifesciences Corp's heart valves to patients at intermediate risk of complications if they underwent open heart surgery. The devices, Sapien XT and Sapien 3, have already been approved for use in patients unlikely to survive open-heart surgery or are at high risk for complications.

  • WELLINGTON, Aug 18- ResMed Inc said on Thursday it has filed legal action to stop the alleged infringement of its patented technology by New Zealand- based medical device manufacturer Fisher& Paykel Healthcare. ResMed said in a statement it filed legal action with the U.S. International Trade Commission and the U.S. District Court for the Southern District of...

  • FRANKFORT, Ky.— The Kentucky Attorney General announced Tuesday that he's seeking thousands of dollars in damages for each patient in the state who got a vaginal mesh implant made by Johnson and Johnson and its medical device unit, accusing the companies of conducting a deceptive marketing campaign. Beshear said in a statement that more than 15,000 women in...

  • Aug 3- Allergan Plc said it would sell its Anda Inc distribution business to Israel's Teva Pharmaceutical Industries Ltd for $500 million, a day after Teva completed its $40.5 billion acquisition of the Dublin- based company's generics business. Anda distributes generic, brand, specialty and over-the-counter pharmaceutical products from more than 300...

  • Excluding one-time items, Edwards said second-quarter earnings rose to 76 cents a share from 57 cents in the year-ago period. The Irvine, California- based company raised its full-year forecast, excluding items, by 11 cents, to a range of $2.78 to $2.88 a share. It now expects sales to be at the high end of the range of its previous forecast of $2.7 billion to $3 billion.

  • Edwards earned 76 cents a share, excluding one-time items, in the second quarter. Analysts on average had expected 70 cents a share, according to Thomson Reuters I/B/E/S. The Irvine, California- based medical device maker raised its full-year forecast, excluding items, by 11 cents, to a range of $2.78 to $2.88 a share.

  • July 21- Theranos Inc hired two executives to oversee regulatory, quality and compliance standards, in a bid to turn around the struggling blood-testing company after it received sanctions from U.S. regulators. He will work on getting FDA clearances and approvals, marketing new products, and look into medical-device quality systems. The company, once valued at...

  • July 19- Two former executives of Acclarent Inc, a medical device company bought by Johnson& Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use. Former Acclarent Chief Executive William Facteau and former Vice President of Sales Patrick Fabian were found guilty in federal court in Boston of 10...

  • July 19- Two former executives of Acclarent Inc, a medical device company bought by Johnson& Johnson in 2010, were convicted on Wednesday by a U.S. jury on charges of promoting a product for an unapproved use. Former Acclarent Chief Executive William Facteau and former Vice President of Sales Patrick Fabian were found guilty in federal court in Boston of 10...

  • *Results affected by Venezuela operations. July 20- Abbott Laboratories reported better-than-expected quarterly sales and profit as strong sales in its medical device business more than made up for the hit from an economic turmoil in Venezuela. Abbott is one of the major U.S. companies to be affected by troubled operations in Venezuela.

  • *Results affected by Venezuela operations. July 20- Abbott Laboratories reported better-than-expected quarterly sales and profit as strong sales in its medical device business more than made up for the hit from an economic turmoil in Venezuela. Abbott, which has four core divisions- nutrition, diagnostics, medical devices and branded generic...

  • Sales in the medical device division rose 6.4 percent to $1.37 billion in the second quarter, driven primarily by better sales of products such as MitraClip that repairs heart valves less invasively. The company, which rakes in two-thirds of its revenue from outside the United States, said results in emerging markets were weighed down by political turmoil in...